Pulmonx Corporation logo
Pulmonx Corporation LUNG
$ 2.54 0.4%

Quarterly report 2025-Q3
added 11-12-2025

report update icon

Pulmonx Corporation Net Debt 2011-2025 | LUNG

Net Debt can be roughly defined as financial liabilities that an entity classifies in the financing section together with the resources available to service those financial liabilities[1]

Net debt is the obligations that remain after deducting all assets and other liabilities from a company or individual. It represents the sum of debts that an organization or person must repay to their creditors or other parties.

Net debt can include various types of obligations such as loans, borrowings, lease liabilities, or credit card payments. It is important to note that net debt does not include current expenses or obligations such as payroll expenses or current bills.

Assessing net debt is an important financial indicator for evaluating the financial position of a company or individual. If net debt significantly exceeds assets, it may indicate financial difficulties and insolvency. In such cases, the company or individual may face difficulties in meeting their obligations and managing their finances.

Net debt can also be used to compare the financial stability of different companies. The lower the net debt relative to assets, the more stable and financially sound they are considered.

Overall, understanding net debt helps evaluate the financial soundness and ability of a company to meet their obligations. It is an important indicator that assists in making decisions about lending, investments, and financial management.

Annual Net Debt Pulmonx Corporation

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-36.1 M -45.4 M -81.3 M -139 M -212 M 13.8 M 29.5 M - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
29.5 M -212 M -67.3 M

References

  1. Pizzo, M., Moscariello, N., & Vinciguerra, R. (2015). Market Incentives and Regulators' Activity Shaping Financial Information: An Analysis of the Net Debt Disclosure in Italy. International Journal of Business and Management, 10(1), 1.

Net Debt of other stocks in the Medical devices industry

Issuer Net Debt Price % 24h Market Cap Country
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
38.7 M - - $ 1.77 B usaUSA
Abiomed Abiomed
ABMD
-227 M - - $ 17.2 B usaUSA
Acutus Medical Acutus Medical
AFIB
14.2 M - -26.83 % $ 2.62 M usaUSA
Apyx Medical Corporation Apyx Medical Corporation
APYX
-10.1 M $ 3.82 -1.04 % $ 132 M usaUSA
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
6.46 M - -5.86 % $ 30.6 M usaUSA
Bio-Rad Laboratories Bio-Rad Laboratories
BIO
754 M $ 307.08 -0.33 % $ 8.66 B usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
-22.5 M - - $ 475 M usaUSA
BioSig Technologies BioSig Technologies
BSGM
252 K - 37.08 % $ 85.7 M usaUSA
Bruker Corporation Bruker Corporation
BRKR
1.91 B $ 45.69 1.24 % $ 6.81 K usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
-3.31 M - 3.58 % $ 2.21 M usaUSA
Abbott Laboratories Abbott Laboratories
ABT
5.26 B $ 128.67 2.55 % $ 224 B usaUSA
Boston Scientific Corporation Boston Scientific Corporation
BSX
8.64 B $ 91.95 -0.67 % $ 135 B usaUSA
Conformis Conformis
CFMS
-26.2 M - - $ 16.4 M usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
230 M - -4.14 % $ 702 M usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
-22.8 M $ 3.18 10.56 % $ 119 M franceFrance
Cardiovascular Systems Cardiovascular Systems
CSII
-64.6 M - 0.15 % $ 844 M usaUSA
Cutera Cutera
CUTR
-140 M - -10.19 % $ 1.99 M usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
-31.6 M - -1.42 % $ 435 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
-9.02 K - -1.98 % $ 98.3 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
-2.3 M - 0.03 % $ 1.58 B israelIsrael
Misonix, Inc. Misonix, Inc.
MSON
5.72 M - - $ 462 M usaUSA
Neovasc Neovasc
NVCN
-4.95 M - - $ 111 M canadaCanada
Eargo Eargo
EAR
-97.8 M - - $ 10.2 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
1.8 M - 14.99 % $ 929 K usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
50.8 M - - $ 955 M usaUSA
Cognyte Software Ltd. Cognyte Software Ltd.
CGNT
-47.4 M $ 9.58 -2.84 % $ 688 M israelIsrael
InMode Ltd. InMode Ltd.
INMD
-34.8 M $ 14.35 -1.1 % $ 1.14 B israelIsrael
IRIDEX Corporation IRIDEX Corporation
IRIX
-4.29 M $ 0.99 7.52 % $ 16 M usaUSA
IRadimed Corporation IRadimed Corporation
IRMD
-52.1 M $ 96.99 0.79 % $ 1.23 B usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
961 K - -0.97 % $ 54.4 M usaUSA
Align Technology Align Technology
ALGN
-925 M $ 163.04 -1.44 % $ 12.2 B usaUSA
Accuray Incorporated Accuray Incorporated
ARAY
73.7 M $ 1.04 -2.06 % $ 107 M usaUSA
Avinger Avinger
AVGR
-16.3 M - -20.74 % $ 369 K usaUSA
ClearPoint Neuro ClearPoint Neuro
CLPT
-16.5 M $ 12.5 -1.66 % $ 338 M usaUSA
FONAR Corporation FONAR Corporation
FONR
-42.8 M $ 14.9 0.99 % $ 97.7 M usaUSA
AxoGen AxoGen
AXGN
21.9 M $ 30.0 -1.3 % $ 1.33 B usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
-230 M - - $ 3.31 B usaUSA
GBS GBS
GBS
-4.38 M - -0.57 % $ 7.12 M usaUSA
CONMED Corporation CONMED Corporation
CNMD
889 M $ 40.3 -1.29 % $ 1.24 B usaUSA
LivaNova PLC LivaNova PLC
LIVN
130 M $ 63.28 0.84 % $ 3.43 B britainBritain
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
31.3 M $ 17.83 1.31 % $ 411 M usaUSA
Globus Medical Globus Medical
GMED
-774 M $ 86.73 0.05 % $ 11.8 B usaUSA
LENSAR LENSAR
LNSR
-13.6 M $ 11.51 -0.04 % $ 133 M usaUSA
Integra LifeSciences Holdings Corporation Integra LifeSciences Holdings Corporation
IART
529 M $ 13.51 0.67 % $ 1.04 B usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
1.36 M - 1.37 % $ 20.5 M usaUSA
Alphatec Holdings Alphatec Holdings
ATEC
442 M $ 19.79 -0.85 % $ 2.83 B usaUSA
Aethlon Medical Aethlon Medical
AEMD
-4.85 M $ 3.07 -9.71 % $ 4.79 M usaUSA
Establishment Labs Holdings Establishment Labs Holdings
ESTA
131 M $ 72.39 -0.17 % $ 2.04 B costa-ricaCosta-rica